Open AccessP1486: TRIALS IN PROGRESS: THE THRIVE STUDIES EVALUATING THE EFFICACY, SAFETY, AND LONG‐TERM TREATMENT WITH INCLACUMAB, A P‐SELECTIN INHIBITOR, IN PATIENTS WITH SICKLE CELL DISEASE
Author(s) -
Andemariam B.,
Inati A.,
Colombatti R.,
Minniti C.,
Brown C.,
Hottmann M.,
Gray S.,
Hoppe C.,
Davis M.,
Yue P.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000848800.77383.3d
Subject(s) - medicine , placebo , clinical endpoint , platelet , endothelium , acute chest syndrome , multicenter trial , hemoglobin , immunology , gastroenterology , sickle cell anemia , clinical trial , randomized controlled trial , pathology , disease , multicenter study , alternative medicine